Plasma Citrulline Level in Relation to Absorptive Surface

Correlation between determination of citrulline in plasma or dried blood

Reference ranges for healthy children and babies

Longitudinal follow-up of citrulline in preterm babies

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intestinal Failure Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Ghent

Ghent, 9000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

0-18 years
preterm babies up to 1.500g
preterm babies over 1.500g

Exclusion criteria

gastro-intestinal problems (except for the preterm babies)
congenital metabolic disorders
dysfunction of the liver or kidneys
congenital defects

Treatment and study plan

blood sampling

Procedure

Blood sampling is used.

Primary outcomes

Correlation between determination of citrulline in plasma or dried blood

Time frame: Untill end of study
Reference ranges for healthy children and babies

Time frame: Until end of study
Longitudinal follow-up of citrulline in preterm babies

Time frame: Untill end of study

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Important dates

Study start: 2005
Primary completion: 2010
Study completion: 2010
First posted: Feb 2, 2006
Registry last updated: Jul 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed